Mental health challenges are widespread in the United States, with a significant portion of the adult population experiencing some form of mental illness. According to the 2022 National Survey on Drug Use and Health (NSDUH), approximately 23.1% of U.S. adults—59.3 million individuals—experienced any mental illness (AMI) in the past year. Of these, 6.0%—15.4 million adults—were classified as having serious mental illness (SMI). These statistics highlight the necessity of accessible, evidence-based mental health interventions, including hypnotherapy, psychological well-being strategies, and trauma-informed care.
The data further reveals disparities in mental health treatment across demographic groups. While roughly half of those with AMI (50.6%) received some form of mental health treatment in the past year, significant variations exist by sex, age, and race. These patterns underscore the importance of culturally competent and age-specific therapeutic approaches. Understanding these trends can inform the development of targeted interventions that address the unique needs of individuals across the mental health spectrum.
Prevalence of Mental Illness in the U.S. Adult Population
The 2022 NSDUH survey provides a comprehensive snapshot of mental health in the United States. It identifies two broad categories of mental illness: Any Mental Illness (AMI) and Serious Mental Illness (SMI). AMI encompasses a wide range of mental, behavioral, or emotional disorders that vary in severity, while SMI represents a smaller subset of AMI characterized by substantial functional impairment.
Among U.S. adults in 2022, the prevalence of AMI was highest among young adults aged 18–25 years, with 36.2% reporting symptoms. This rate declines with age, with 29.4% of adults aged 26–49 and 13.9% of those aged 50 and older experiencing AMI. Similarly, SMI prevalence peaks in young adults, affecting 11.6% of those aged 18–25, compared to 7.6% in the 26–49 age group and 3.0% in those aged 50 and older.
Sex also plays a role in the prevalence of mental illness. Females reported higher rates of both AMI (26.4%) and SMI (7.1%) than males (19.7% and 4.8%, respectively). These differences may be influenced by a range of factors, including biological, psychological, and sociocultural variables.
Racial and ethnic disparities are also evident in the data. Adults reporting two or more races had the highest prevalence of AMI (35.2%) and SMI (11.8%), followed by White adults (24.6% for AMI and 6.1% for SMI). In contrast, Native Hawaiian/Other Pacific Islander adults reported the lowest SMI prevalence at 3.5%. These patterns emphasize the need for culturally sensitive care that accounts for the diverse experiences of different populations.
Mental Health Treatment and Access to Care
Despite the high prevalence of mental illness, only about half of individuals with AMI received mental health treatment in the past year. In 2022, 30.0 million adults (50.6%) with AMI accessed some form of treatment, including inpatient or outpatient counseling and prescription medication. However, treatment rates varied significantly across demographic groups.
Females with AMI were more likely to receive treatment than males, with 56.9% of women seeking care compared to 41.6% of men. This disparity may reflect differences in help-seeking behaviors, social support, or the types of mental health services available to different populations.
Age also influenced treatment rates. While 49.1% of young adults aged 18–25 with AMI received treatment, this rate increased with age, reaching 52.7% for adults aged 50 and older. These findings suggest that older adults may be more inclined to seek help or may have better access to healthcare resources.
Racial and ethnic differences in treatment access are also notable. White adults had the highest treatment rate for AMI (56.1%), while Hispanic or Latino adults had the lowest at 39.6%. These disparities highlight the need for targeted outreach and policy interventions to improve mental health care access for underserved communities.
For individuals with SMI, treatment rates were higher overall. In 2022, 66.7% of adults with SMI received mental health treatment. However, significant differences persisted by sex, age, and race. For example, 71.4% of females with SMI received treatment compared to 59.3% of males, and treatment rates increased with age, from 57.9% among young adults to 71.0% among those aged 50 and older.
Implications for Therapeutic Practice and Policy
The data on mental illness prevalence and treatment access have important implications for therapeutic practice and public health policy. Given the high rates of untreated mental illness, especially among males and younger adults, there is a clear need for proactive interventions that encourage help-seeking behaviors and reduce barriers to care.
Hypnotherapy and other evidence-based therapeutic interventions can play a valuable role in addressing mental health challenges. These approaches may be particularly effective for individuals with anxiety, phobias, and emotional regulation difficulties. However, the success of such interventions depends on their accessibility and cultural relevance.
Policy efforts should focus on expanding mental health services in underserved communities and addressing systemic inequities in care. This includes increasing funding for mental health programs, improving insurance coverage for mental health treatment, and training healthcare providers in culturally competent care.
Conclusion
Mental illness is a significant public health issue in the United States, affecting millions of adults each year. While treatment rates have improved, disparities persist across demographic groups, underscoring the need for targeted interventions and policy reforms. Understanding the patterns of mental illness prevalence and treatment access is essential for developing effective therapeutic strategies and improving mental health outcomes for all individuals.